Navigation Links
Hospice Community Encouraged to Respond to Daschle Request to Participate in Information Gathering about Healthcare Concerns
Date:12/11/2008

NHPCO and NHF support call for Americans to "Tell Their Stories"

ALEXANDRIA, Va., Dec. 11 /PRNewswire-USNewswire/ -- President-Elect Obama has indicated that healthcare reform will be a top priority in his administration. Senator Tom Daschle, who has accepted Obama's offer to serve as health and human services secretary, is the leader of the Transition's Health Policy Team. Daschle is asking Americans to help with reform efforts by sharing their healthcare experiences and concerns. Recommendations that the transition team will provide to the new administration will include some of the information provided by the American public.

National Hospice and Palliative Care Organization and the National Hospice Foundation are encouraging all hospice supporters to participate in this process to help the administration better understand what is important regarding end-of-life care in this country.

"The need for people to tell their stories is one that we've longed championed as part of our grassroots advocacy work in the hospice community," said J. Donald Schumacher, president/CEO of NHPCO and NFH. "There is no better way to understand the healthcare needs of our nation than by hearing the stories from concerned citizens."

While details of Obama's healthcare proposals will not be known for some time, Daschle has initiated the information gathering process. The strategy begins with an invitation for people across the nation to hold what are being thought of as "house parties" from December 15 to 31, 2008, with the intention of sharing concerns and experiences. Information gathered from these informal gatherings may then be posted on the Web site, http://change.gov.

NHPCO and NHF are asking hospice and palliative care providers and end-of-life coalitions to host a healthcare discussion in homes or communities from Decembe
'/>"/>

SOURCE National Hospice and Palliative Care Organization
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. In-House Hospice Offers Help to Those Living With Grief During Holiday Time
2. NHPCO Reports Growth in Number of Hospice Patients Served, 1.4 Million, With a Wider Range of Illnesses Seen by Providers
3. Global Med Technologies(R), Inc.s Inlog Subsidiary Places Transfusion Management Software in Five Hospitals of the Civil Hospices of Lyon
4. Children with Life-Threatening Illnesses Receive Hospice Care
5. Deck of Cards is More Than a Game: Integral in Silverado Hospice Care
6. LodgeNet Healthcare Expands Into Hawaii Through Agreement With St. Francis Hospice
7. Signature Hospice Team Grants Patients Unusual Wish
8. Elizabeth Edwards to be Opening Speaker at National Hospice Conference in Dallas
9. VITAS Innovative Hospice Care Signs Agreement with Aetna
10. The Connecticut Hospice, Inc. Announces the Arrival of Six Nurse Scholars From The Henrietta Szold-Hadassah-Hebrew University School of Nursing
11. Connecticut Hospice Has Miss Fairfield on Its Side

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...2 Holly Potter, vice president, Pu...agement for Kaiser Permanente, received the "PR Te...held at the National Press Club. ,, PR News,...nnovators and professionals who day in and day out...ce. The winners of this year,s program set the ben...
(Date:12/2/2009)...., Dec. 2 From more than 1,100 pho...ning, joy and peace, the LIFE Foundation has selec...d using the popular photo-sharing Web site flickr....ontage on the LIFE Foundation,s Web site at www.l...submitted one photo and a caption to Flickr.com du...
(Date:12/2/2009)...c. 2 US Farms, Inc. (Pin..., Nursery and Wellness products, is pleased to ann...ts at the Cook,sware A,faire in Oakland, Calif., a...or additional information, contact US Farms, Inc. ...it http://cookswareafaire.com ,, Victor Brand...
(Date:12/2/2009)...., Dec. 2 Watson Pharmac... the Federal Trade Commission (FTC) has accepted a...g to Watson,s pending acquisition of privately hel... the Hart Scott Rodino waiting period, thereby per... parties have now obtained all regulatory approval...
(Date:12/2/2009)...Red Cross also part of the Hewlett-Packard Company...2 The Hewlett-Packard C...lion this year to help fund American Red Cross dis...com/cgi-bin/prnh/20090108/RedCrossLOGO ) ,, Th...p Philippine communities affected by typhoons in S...
Breaking Medicine News(10 mins):Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 3Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:US Farms, Inc. Showcasing Aloe365(TM) Product Line at Cook'sware A'faire at Oakland Zoo 2Health News:Watson Receives FTC Clearance for Arrow Acquisition 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 3
...egions right before an error is made , , W...hile performing repetitive tasks, people make mist...ce of a pattern of activity across two regions of ...a function of instantaneous brain blips, while als...
...rmany of a myocardial infarction is not higher for...ches rzteblatt International (Dtsch Arztebl Int 20...describe how they disproved this widely held view....general statutory health insurance company) patien...
...ents from 11 to 17 years of age smoke. This was th... and Examination Survey for Children and Adolescen... and presented by the sociologist Thomas Lampert i...en and adolescents covered almost 7,000 girls and ...
...Day is traditionally filled,with joy and honor for...stock, Ga., the coming of Mother,s Day was nearly ...d at age 18 with a rare liver disease. After she a...be,declined help because of her liver issues., Sa...
...onal Women,s Health Week and supports the ...THRIDGE, Calif., April 23 American Idol breakout,...ll perform a concert on,May 15, 2008 in honor of N...tion and easy to swallow, in support of the,Societ...
... Impact on Employer Health Care Offerings Thus ...ril 23 Most U.S. companies do,not support a singl...ndating coverage. Instead, they prefer relying on ...., More than three-quarters (84 percent) of emplo...
Other Medicine News:Health News:Brain Patterns Predict Mistakes 2Health News:Brain Patterns Predict Mistakes 3Health News:Mother's Day Gives Woman Reason to Celebrate Life's Most Precious Gift 2Health News:Nature Made(R) Liquid Softgels Presents American Idol's Kimberley Locke Live in Concert 2Health News:Nature Made(R) Liquid Softgels Presents American Idol's Kimberley Locke Live in Concert 3Health News:Nature Made(R) Liquid Softgels Presents American Idol's Kimberley Locke Live in Concert 4Health News:Most Companies Oppose Single-Payer Health Care System, State Coverage Mandates 2
(Date:12/2/2009)...ecember 2 Cardio Vascula...per of advanced,cardiovascular surgery technology,...tors approved a one-for-three forward stock split,...o Vascular Medical Device shareholders. , ...ated date the stock,split will be payable and the ...
(Date:12/2/2009)...2 Roche (SIX: RO, ROG; O...s Food & Drug Administration (FDA) approved an...acid test, to screen source plasma in pools compri...lled the cobas® TaqScreen MPX Test for use on...tro test for the simultaneous, direct detection of...
(Date:12/2/2009)...., Dec. 2 Novartis announced today...tion on Tasigna® (nilotinib) 200 mg capsules ... the strength of the company,s hematology portfoli...w data, at the 51st American Society of Hematology...e company,s current therapies and investigational ...
Breaking Medicine Technology:Cardio Vascular Medical Device Announces Forward Stock Split 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25American Medical Informatics Association 28AMIA 29 Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certifi 13045 1American Medical Informatics Association 28AMIA 29 Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certifi 13045 2National Coalition of Mental Health Consumer Survivor Organizations Hires Director of Government Relations 51792 1National Coalition of Mental Health Consumer Survivor Organizations Hires Director of Government Relations 51792 2Proposed Water Trust Fund Bill Would Provide Solid Foundation for Improvement 51788 1Proposed Water Trust Fund Bill Would Provide Solid Foundation for Improvement 51788 2
...ene Activity and Metabolic,Enzymes Show How Cells ...zyme A, a Key Player in the Daily Biochemical Rout...2007 /PRNewswire/ -- Investigators at,St. Jude Chi...the,dynamic genetic and biochemical changes that m...le called Coenzyme A (CoA), a key,player in metabo...
...07 /PRNewswire/ -- DiObex,Inc., a privately- held...ent of therapeutics to treat metabolic diseases, t...902, a novel Cortisol,Synthesis Inhibitor. , In a ...bo-controlled trial, patients with type 2 diabetes..., pharmacokinetics and,activity of three dose leve...
Other Medicine Technology:Study Shows Metabolic Strategy of Stressed Cell 2Study Shows Metabolic Strategy of Stressed Cell 3Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 2Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 3
Woodson Elevator
Henner Elevator
Tenzel Double-Ended Periosteal Elevator
DesMarres Lid Retractor
Medicine Products: